280 related articles for article (PubMed ID: 28618988)
21. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.
Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F
Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378
[TBL] [Abstract][Full Text] [Related]
22. Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
Abdel-Rahman HM; Abdel-Aziz M; Canzoneri JC; Gary BD; Piazza GA
Arch Pharm (Weinheim); 2014 Sep; 347(9):650-7. PubMed ID: 24985336
[TBL] [Abstract][Full Text] [Related]
23. Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity.
Abd El-Aleam RH; George RF; Lee KJ; Keeton AB; Piazza GA; Kamel AA; El-Daly ME; Hassan GS; Abdel-Rahman HM
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900002. PubMed ID: 31353608
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design of selective phosphodiesterase 4B inhibitors based on ginger phenolic compounds.
Xing M; Akowuah GA; Gautam V; Gaurav A
J Biomol Struct Dyn; 2017 Oct; 35(13):2910-2924. PubMed ID: 27608741
[TBL] [Abstract][Full Text] [Related]
25. 1,8-Naphthyridines VI. Synthesis and anti-inflammatory activity of 5-(alkylamino)-N,N-diethyl[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides with a new substitution pattern on the triazole ring.
Di Braccio M; Grossi G; Roma G; Piras D; Mattioli F; Gosmar M
Eur J Med Chem; 2008 Mar; 43(3):584-94. PubMed ID: 17602797
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors.
Goto T; Shiina A; Yoshino T; Mizukami K; Hirahara K; Suzuki O; Sogawa Y; Takahashi T; Mikkaichi T; Nakao N; Takahashi M; Hasegawa M; Sasaki S
Bioorg Med Chem; 2013 Nov; 21(22):7025-37. PubMed ID: 24094436
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment.
Zhang R; Li H; Zhang X; Li J; Su H; Lu Q; Dong G; Dou H; Fan C; Gu Z; Mu Q; Tang W; Xu Y; Liu H
Eur J Med Chem; 2021 Feb; 211():113004. PubMed ID: 33218684
[TBL] [Abstract][Full Text] [Related]
28. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses.
Zhou ZZ; Cheng YF; Zou ZQ; Ge BC; Yu H; Huang C; Wang HT; Yang XM; Xu JP
ACS Chem Neurosci; 2017 Jan; 8(1):135-146. PubMed ID: 27690383
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis and Molecular Docking Studies of Novel Thiadiazole Analogues with Potential Antimicrobial and Antiinflammatory Activities.
Mehta DK; Taya P; Das R; Dua K
Antiinflamm Antiallergy Agents Med Chem; 2019; 18(2):91-109. PubMed ID: 30848217
[TBL] [Abstract][Full Text] [Related]
30. Exploring the Role of Water Molecules in the Ligand Binding Domain of PDE4B and PDE4D: Virtual Screening Based Molecular Docking of Some Active Scaffolds.
Singh P; Mishra M; Agarwal S; Sau S; Iyer AK; Kashaw SK
Curr Comput Aided Drug Des; 2019; 15(4):334-366. PubMed ID: 30394213
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Thiazole Based Bis Heterocyclic System for Anti- Inflammatory Potential.
Tapkir AS; Chitlange SS; Bhole RP
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(3):175-192. PubMed ID: 29141567
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis.
Purushothaman B; Arumugam P; Kulsi G; Song JM
Eur J Med Chem; 2018 Feb; 145():673-690. PubMed ID: 29353721
[TBL] [Abstract][Full Text] [Related]
33. Discovery of 2-(3,4-dialkoxyphenyl)-2-(substituted pyridazin-3-yl)acetonitriles as phosphodiesterase 4 inhibitors with anti-neuroinflammation potential based on three-dimensional quantitative structure-activity relationship study.
Huang C; Zhong QP; Tang L; Wang HT; Xu JP; Zhou ZZ
Chem Biol Drug Des; 2019 Apr; 93(4):484-502. PubMed ID: 30588755
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 5-phenyl-1-(3-pyridyl)-1H-1,2,4-triazole-3-carboxylic acid derivatives of potential anti-inflammatory activity.
Rabea SM; El-Koussi NA; Hassan HY; Aboul-Fadl T
Arch Pharm (Weinheim); 2006 Jan; 339(1):32-40. PubMed ID: 16411174
[TBL] [Abstract][Full Text] [Related]
35. Discovery of arylbenzylamines as PDE4 inhibitors with potential neuroprotective effect.
Tang L; Huang C; Zhong J; He J; Guo J; Liu M; Xu JP; Wang HT; Zhou ZZ
Eur J Med Chem; 2019 Apr; 168():221-231. PubMed ID: 30822711
[TBL] [Abstract][Full Text] [Related]
36. DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
Li H; Li J; Zhang X; Feng C; Fan C; Yang X; Zhang R; Zhu F; Zhou Y; Xu Y; Liu H; Tang W
Biochem Pharmacol; 2020 Jul; 177():113958. PubMed ID: 32251674
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.
Lin Y; Ahmed W; He M; Xiang X; Tang R; Cui ZN
Eur J Med Chem; 2020 Dec; 207():112795. PubMed ID: 33002845
[TBL] [Abstract][Full Text] [Related]
38. Rational design of conformationally constrained oxazolidinone-fused 1,2,3,4-tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.
Song G; Zhu X; Li J; Hu D; Zhao D; Liao Y; Lin J; Zhang LH; Cui ZN
Bioorg Med Chem; 2017 Oct; 25(20):5709-5717. PubMed ID: 28888661
[TBL] [Abstract][Full Text] [Related]
39. New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies.
Guariento S; Bruno O; Fossa P; Cichero E
Mol Divers; 2016 Feb; 20(1):77-92. PubMed ID: 26290462
[TBL] [Abstract][Full Text] [Related]
40. Novel imidazophenoxazine-4-sulfonamides: their synthesis and evaluation as potential inhibitors of PDE4.
Reddy SV; Rao GM; Kumar BV; Meda CL; Deora GS; Kumar KS; Parsa KV; Pal M
Bioorg Med Chem; 2013 Apr; 21(7):1952-63. PubMed ID: 23415088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
